-
-
Integrated Diagnostics Holdings plc reports year-on-year revenue growth of 34% in 9M 2024 with improving margins
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading provider of diagnostic services with operations in Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia, announced today its unaudited financial statements for the nine-month period ended...
-
-
Integrated Diagnostics Holdings plc delivers strong 33% year-on-year revenue growth in 1H 2024
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading provider of diagnostic services with operations in Egypt, Jordan, Nigeria, Sudan and Saudi Arabia, announced today its unaudited financial statements for the six-month period ended...
-
-
EGX Delisting – timeline under EGX’s special operations market (OPR)
Integrated Diagnostics Holdings plc ("IDH" or the "Company") refers to the shareholder resolutions passed at the Company's Extraordinary General Meetings held on 12 June 2024 and 18 July 2024 approving, amongst other things, the voluntary delisting (the "EGX Delisting") of...
-
-
IDH’s proposed revised Delisting Buyback Price in connection with delisting from the Egyptian Exchange
(Cairo and London) — Integrated Diagnostics Holdings plc (“IDH”, the “Company” or the “Group”), a leading consumer healthcare company operating in Egypt, Jordan, Sudan, Nigeria, and Saudi Arabia, announces that on 24 May 2024, it published a Notice of the...
-
-
IDH Releases Q1 2024 Financial Results
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading provider of diagnostic services with operations in Egypt, Jordan, Nigeria, Sudan and Saudi Arabia, announced today its reviewed financial statements for the quarter ended 31 March...
-
-
IDH proposing to delist its shares from the Egyptian Exchange
(Cairo and London) — Integrated Diagnostics Holdings plc ("IDH", the "Company" or the "Group"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, Nigeria and Saudi Arabia, today announces that the directors of the Company (the “Board”...
-
-
IDH Releases FY 2023 Financial Results
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading provider of diagnostic services with operations in Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia, announced today its audited financial statements and operational performance for the year...
-
-
IDH Releases 9M 2023 Financial Results
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading provider of diagnostic services with operations in Egypt, Jordan, Nigeria, Sudan, and soon launching in Saudi Arabia, announced today its reviewed financial statements for the nine-month...
-
-
IDH CEO increases stake in the Company
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading provider of diagnostics services with operations in Egypt, Jordan, Nigeria, Sudan, and soon launching in Saudi Arabia, announced today that its Chief Executive Officer, Dr. Hend...
-
-
IDH Releases 1H 2023 Financial Results
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading provider of diagnostic services with operations in Egypt, Jordan, Nigeria, Sudan, and soon launching in Saudi Arabia, announced today its reviewed financial statements for the six-month...
-
-
IDH Releases Q1 2023 Financial Results
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Nigeria and Sudan, released today its reviewed financial statements and operational performance for the quarter ended 31 March...
-
-
IDH Releases FY 2022 Financial Results
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Nigeria and Sudan, released today its audited financial statements and operational performance for the year ended 31 December...
-
-
Dr. Hend El-Sherbini named in Forbes Middle East 100 Most Powerful Businesswomen of 2023
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, is pleased to announce that Group CEO, Dr. Hend El-Sherbini, was name as one...
-
-
IDH to no longer pursue acquisition of IDC stake
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, announces that it will no longer pursue negotiations for the acquisition of a 50% stake...
-
-
IDH Releases 9M 2022 Financial Results
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its reviewed financial statements and operational performance for the nine-month period ended 30...
-
-
IDH to Launch Greenfield Diagnostic Venture in Saudi Arabia
(Cairo and London) - Integrated Diagnostics Holdings ("IDH," "the Company" or "the Group"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces the signing of a Joint Venture (“JV”) Agreement with Al Makhbaryoun Al Arab...
-
-
IDH launches sixth Al-Borg Scan Branch in Cairo’s Maadi Neighbourhood
(Cairo and London) — Integrated Diagnostics Holdings ("IDH," "the Company" or "the Group"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces the launch of Al-Borg Scan’s sixth branch. The branch will be located in Cairo’s...
-
-
Al-Borg Scan’s Nuclear Medicine and Ultrasound Units Earn Prestigious ACR Accreditation
(Cairo and London) — Integrated Diagnostics Holdings ("IDH," "the Company" or "the Group"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces that its radiology venture, Al-Borg Scan, has obtained ACR (American College of Radiology) accreditation...
-
-
IDH Releases 1H2022 Financial Results
(Cairo and London) —Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its reviewed financial statements and operational performance for the six-month period ended 30 June...
-
-
SPA for IDH’s acquisition of a stake in IDC expires; negotiations to continue
(Cairo and London) — In relation to the share purchase agreement (the "SPA") signed on 20 December 2021 by IDH (or "the Company") for the acquisition of a 50% stake in Islamabad Diagnostic Center ("IDC"), IDH has notified Evercare IGA Holdings...
-
-
IDH CEO ups stake in the Company
(Cairo and London) — Dr. Hend El Sherbini, Integrated Diagnostics Holdings' chief executive officer, has purchased 7.3 million additional shares in the Company. This is in line with her commitment to deliver on the Company's growth and value creation strategy. The...
-
-
Statement regarding final dividend declared on 7 June 2022
(Cairo and London) — Integrated Diagnostics Holdings plc (“IDH” or “the Company”), is happy to announce that it has begun paying out a final dividend equivalent to EGP 2.17 per share (EGP 1.3 billion in aggregate) in respect of the year...
-
-
IDH RELEASES 1Q2022 FINANCIAL RESULTS
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its reviewed financial statements and operational performance for the quarter ended 31 March...
-
-
IDH RELEASES FY2021 FINANCIAL RESULTS
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its audited financial statements and operational performance for the year ended 31 December...
-
-
IFC and IFC MENA Fund acquire 5% stake in IDH
(Cairo and London) - Integrated Diagnostics Holdings ("IDH," or "the Group"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces that the shareholding of IDH held jointly by the International Finance Corporation (“IFC”) and IFC...
-
-
IDH launches fifth Al-Borg Scan branch in West Cairo’s Capital Business Park
(Cairo and London) - Integrated Diagnostics Holdings ("IDH," "the Company" or "the Group"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces the launch of Al-Borg Scan’s fifth branch. The branch will be located in...
-
-
IDH Welcomes Visit from Siemens Healthineers
(Cairo and London) - Integrated Diagnostics Holdings is pleased to announce that on Monday, 21 March 2022, the Company welcomed a visit at the Group’s headquarters from the Siemens Healthineers’ CEO for Europe, Africa, and the Middle East, Dr. Bernd...
-
-
IDH announces the appointment of Ms Yvonne Stillhart, as a Non-Executive Director of the Company
(Cairo and London) - The Board announces the appointment of Ms Yvonne Stillhart, as a Non-Executive Director of the Company with effect from 1 March 2022. Yvonne also joins the Audit and the Remuneration Committees. Tap or click here to...
-
-
Pakistan’s Ambassador to Egypt visits IDH headquarters to explore relationships between IDH and Pakistani companies
(Cairo and London) - Integrated Diagnostics Holdings ("IDH," "the Company" or "the Group"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, welcomed a visit from H.E. Ambassador Sajid Bilal, Pakistan's Ambassador to Egypt, to the...
-
-
IDH to acquire Evercare Group’s 50% stake in Islamabad Diagnostic Centre (IDC)
(Cairo and London) - Integrated Diagnostics Holdings ("IDH," "the Company" or "the Group"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, today announced the signing of a sale and purchase agreement (the “SPA”) to acquire...
-
-
IDH RELEASES 9M2021 FINANCIAL RESULTS
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its reviewed financial statements and operational performance for the nine-month period ended 30...
-
-
IDH launches third Al-Borg Scan branch in East Cairo’s centrally-located Heliopolis neighbourhood
(Cairo and London) - Integrated Diagnostics Holdings ("IDH," "the Company" or "the Group"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces the launch of Al-Borg Scan’s third branch. The new branch is located in...
-
-
IDH RELEASES 1H2021 FINANCIAL RESULTS
(London and Cairo) Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its reviewed financial statements and operational performance for the first half of 2021,...
-
-
Biolab, IDH’s Jordanian subsidiary, selected as preferred bidder to operate testing stations in Amman’s Queen Alia International Airport
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces that Biolab, IDH’s Jordanian subsidiary, has been selected as the preferred bidder by Airport...
-
-
IDH Chief Executive Officer, Dr. Hend El-Sherbini, participates in IFC virtual webinar on leadership in healthcare quality in Egypt
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, is pleased to announce that Group CEO, Dr. Hend El-Sherbini, will be one of...
-
-
IDH RELEASES 1Q2021 FINANCIAL RESULTS
(London and Cairo) Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its unaudited highlights of its financial and operational performance in the first three...
-
-
IDH partners with IFC on a USD 45 million debt financing package
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces that it has secured a USD 45 million debt financing package from the International...
-
-
IDH Debuts Trading on EGX
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces that its EGP-denominated and dual-listed ordinary shares begin...
-
-
IDH RELEASES FY2020 FINANCIAL RESULTS
(London) Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its results for the year ended 31 December 2020, reporting revenues of EGP 2,656 million...
-
-
IDH receives approval from the Egyptian Exchange for the dual listing of its ordinary shares
(Cairo and London) — Integrated Diagnostics Holdings ("IDH," "the Company" or "the Group," IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces that it has received approval from the...
-
-
IDH receives FRA registration approval as a preliminary step for its dual listing and trading on the Egyptian Exchange
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces that it has received approval from the...
-
-
Trading update for the year ended 31 December 2020
(London) Integrated Diagnostics Holdings ("IDH," "the Group," or "the Company"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today a trading update for the year ended 31 December 2020 based on its unaudited financial...
-
-
IDH exploring a possible dual listing on the Egyptian Exchange
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, notes the recent press speculation and confirms that...
-
-
IDH releases 1H2020 financial results
(London) Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its results for the year ended 31 December 2019, reporting revenues of EGP 2,226 million...
-
-
IDH releases 1Q2020 financial results
(London) Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its results for the year ended 31 December 2019, reporting revenues of EGP 2,226 million...
-
-
IDH releases FY2019 financial results
(London) Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, released today its results for the year ended 31 December 2019, reporting revenues of EGP 2,226 million...
-
-
Integrated Diagnostics Holdings Plc Covid-19 Guidelines
(London) – As the novel coronavirus that causes the covid-19 illness continues to spread across the globe, Integrated Diagnostics Holdings (IDH) is closely monitoring the situation in our markets. We have begun implementing measures we believe are necessary to guarantee...
-
-
IDH launches new subsidiary “Wayak” to offer data-driven healthcare support
(Cairo and London) - Integrated Diagnostics Holdings ("IDH," "the Group," or "the Company"), IDHC on the London Stock Exchange, a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, announces the launch of its new Egypt-based subsidiary...
-
-
IDH releases 1H2019 financial results
(London) Integrated Diagnostics Holdings ("IDH," "the Group," or "the Company"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, announces today its results for the six-month period ended 30 June 2019, reporting a 23% year-on-year increase...
-
-
IDH releases FY2018 financial results
(London) Integrated Diagnostics Holdings ("IDH," "the Group," or "the Company"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, announces its results for the year ended 31 December 2018, reporting a net profit of EGP 497...
-
-
Appointment of J.P. Morgan Cazenove as Corporate Broker
(Cairo and London) - Integrated Diagnostics Holdings ("IDH" or "the Company"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, announced today that it has appointed J.P. Morgan Cazenove as Corporate Broker. -Ends- About Integrated...
-
-
Integrated Diagnostics Holdings Plc Notice of results
(London) - Integrated Diagnostics Holdings ("IDH," "the Group," or "the Company"), IDHC on the London Stock Exchange, a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, will publish its results for the year ended 31 December...
-
-
IDH subsidiary Biolab signs agreement with Georgia Healthcare Group to establish a Mega Lab
The facility will be the largest of its kind in Georgia and the region with enough capacity to deliver high quality clinical and pathology tests to the country’s entire population (Cairo and London) – Integrated Diagnostics Holdings (“IDH” or “the...
-
-
IDH launches new Nigerian medical diagnostics business Echo-Lab
Integrated Diagnostics Holdings, a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, recently launched the rebranding of Echo-Lab, its radiology and laboratory service in Nigeria. IDH aims to transform Echo-Lab into Nigeria's market leading medical diagnostics...
-
-
IDH launches radiology business in fast-growing Egyptian market
A strategic expansion that is set to transform IDH’s Egyptian operation into a one-stop-shop diagnostics service provider; the investment is planned to have limited impact on cashflows Integrated Diagnostics Holdings (“IDH,” “the Company” or “the Group,” IDHC on the London...
-
-
Investment in Nigeria’s Echo-Scan
Integrated Diagnostics Holdings and Man Capital partner with the International Finance Corporation to invest in Nigeria’s Echo-Scan Dynasty Group Holdings is a joint venture between Integrated Diagnostics Holdings and Man Capital LLP Dynasty and the International Finance Corporation (“IFC”)...
Media Contact
Tarek Yehia
Investor Relations Director
T: +20 (0)2 3332 1126
M: +20 10 6882 6678
E-mail: tarek.yehia@idhcorp.com